Novartis reported $21.24B in Loan Capital for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Amgen AMGN:US USD 37.16B 1.46B
AstraZeneca AZN:LN USD 23.68B 3.47B
Astrazeneca AZN:US USD 23.68B 3.47B
Biogen BIIB:US USD 6.28B 1.8M
Bristol Myers Squibb BMY:US USD 36.97B 141M
Canopy Growth Corp WEED:CN CAD 1.12B 239.18M
Catalent CTLT:US USD 4.1B 73M
Eli Lilly And LLY:US USD 14.14B 548.2M
Endo International Ordinary Shares ENDP:US USD 1.42M 8.05B
Glaxosmithkline GSK:US GBP 21.56B 1.31B
GlaxoSmithKline GSK:LN GBP 19.32B 538M
Horizon Pharma HZNP:US USD 2.55B 1.85M
Lannett LCI:US USD 619.34M 4.39M
Novartis NOVN:VX USD 21.24B 2.55B
Pacira Pharmaceuticals PCRX:US USD 714M 7.88M
Perrigo Ordinary Shares PRGO:US USD 4.08B 8.6M
Prestige Brands PBH:US USD 1.44B 34.8M
Teva Pharmaceutical Industries TEVA:US USD 18.5B 1.87B
Valeant Pharmaceuticals VRX:CN USD 20.8B 860M
Zoetis ZTS:US USD 5.21B 11M